Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,853 | -13,451 | -24,732 | -29,056 | -43,618 |
| Depreciation Amortization | 2,267 | 1,613 | 1,626 | 1,370 | 810 |
| Accounts receivable | 3,495 | -21,740 | 27,145 | -34,572 | 25,444 |
| Accounts payable and accrued liabilities | N/A | N/A | -8,957 | 15,424 | -2,473 |
| Other Working Capital | -3,271 | -9,905 | -3,889 | -3,003 | 24,258 |
| Other Operating Activity | 2,807 | 27,265 | -12,068 | 24,838 | -19,632 |
| Operating Cash Flow | $-28,555 | $-16,218 | $-20,874 | $-24,998 | $-15,211 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 546 | -11,666 | 12,606 | -11,690 | -10,955 |
| PPE Investments | -325 | -604 | -1,212 | -3,344 | -1,398 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -136 |
| Other Investing Activity | 0 | -625 | 0 | 0 | -136 |
| Investing Cash Flow | $221 | $-12,895 | $11,394 | $-15,033 | $-12,489 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 836 | 48,051 | 667 | 66,769 | 2,961 |
| Common Stock Repurchased | -5 | -155 | N/A | N/A | N/A |
| Financing Cash Flow | $831 | $47,896 | $667 | $66,769 | $2,961 |
| Beginning Cash Position | 41,125 | 22,342 | 31,155 | 4,418 | 29,157 |
| End Cash Position | 13,622 | 41,125 | 22,342 | 31,155 | 4,418 |
| Net Cash Flow | $-27,503 | $18,783 | $-8,813 | $26,738 | $-24,739 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,555 | -16,218 | -20,874 | -24,998 | -15,211 |
| Capital Expenditure | -325 | -604 | -1,212 | -3,344 | -1,398 |
| Free Cash Flow | -28,880 | -16,822 | -22,086 | -28,342 | -16,610 |